Huntsman (HUN) Q4 2016 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2016 earnings summary
3 Nov, 2026Executive summary
Generated record free cash flow of $686 million in 2016, nearly double the $350 million commitment; repaid $560 million of debt and strengthened the balance sheet.
Differentiated MDI volumes rose 6% and represented 85% of MDI EBITDA; total MDI EBITDA increased 9% YoY.
Financial highlights
FY 2016 revenue was $9.657 billion, down 6% YoY; gross profit fell 9% to $1.678 billion, while operating income rose to $647 million from $405 million.
Net income attributable to shareholders was $326 million vs. $93 million in 2015; adjusted net income was $377 million vs. $492 million, and adjusted diluted EPS was $1.57 vs. $2.00.
Adjusted EBITDA was $1.127 billion, down 8% YoY; operating cash flow increased to $1.088 billion from $575 million.
Adjusted for the $98 million pretax gain on the European surfactants sale, other operating income, net, increased; 2016 restructuring costs were $81 million vs. $302 million in 2015.
Outlook and guidance
2017 free cash flow is expected to exceed $350 million; planned capital expenditures are approximately $400 million, with funding expected from operating cash flow.
Adjusted effective tax rate is expected to be slightly below the approximately 30% long-term rate in 2017; the 2016 adjusted rate was 22%.
Pigments and Additives separation was targeted for Q2 2017; approximately $100 million of non-recurring separation costs were expected in 2017, including capital and financing costs.
Advanced Materials outlook cited a strong aerospace market representing more than one-third of segment earnings; planned maintenance and lower-than-historical margins were expected in parts of other segments.
Latest events from Huntsman
- Revenue held near $11.1B, but reported earnings and EBITDA fell sharply.HUN
Q4 2013 - FY11 growth strengthened, but restructuring and uneven segment performance shaped the outlook.HUN
Q4 2011 - Record 2004 growth and IPO-led deleveraging, offset by restructuring charges and market uncertainty.HUN
Q4 2004 - Record adjusted EBITDA topped $1.39B, led by Polyurethanes strength.HUN
Q4 2012 - Cyclical and TiO2 weakness cut earnings as downstream differentiation and cash-flow improvement remained priorities.HUN
Q4 2015 - Settlement cash strengthened liquidity as recession pressure drove operating income sharply lower.HUN
Q4 2008 - Recovery lifted sales and Adjusted EBITDA, but debt costs and cash outflow weighed on earnings.HUN
Q4 2010 - Recession cut annual revenue 24%, while settlement income lifted reported EBITDA to $1.158B.HUN
Q4 2009 - Adjusted EBITDA rose to $132M; Q4 guidance is $60M–$80M as the Olin merger targets Q1 2027.HUN
Q3 2026